You are here
Molecular Templates Appoints Roger J. Waltzman, M.D., as Chief Medical Officer
AUSTIN, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer, today announced the appointment of Roger J. Waltzman, M.D., as Chief Medical Officer, effective Tuesday February 19, 2019. Dr. Waltzman will report to Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer of Molecular Templates, and will be responsible for all clinical development and regulatory activities.
Tuesday, February 19, 2019 - 16:30